ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Topic: Akebia

Venture firms bet $41M more on P&G spinout developing oral anemia drug

Venture firms bet $41M more on P&G spinout developing oral anemia drug

June 4, 2013 2:41 pm by | 0 Comments

Akebia Therapeutics might be a bit behind in the race to develop a safer, oral drug for anemia, but it’s just gotten a big vote of confidence from investors in ... Read more
Vascular disease biopharma Aerpio nabs $27M for trials of diabetic macular edema drug

Vascular disease biopharma Aerpio nabs $27M for trials of diabetic macular edema drug

August 30, 2012 2:33 pm by | 0 Comments

A biopharmaceutical company that spun out of Cincinnati-based Akebia Therapeutics just eight months ago has raised $27 million to support development and clinical trials of its drug for diabetic macular ... Read more
Oral anemia drug meets primary endpoints in phase 2 trial

Oral anemia drug meets primary endpoints in phase 2 trial

April 5, 2012 2:54 pm by | 0 Comments

A once-daily oral anemia drug from Akebia Therapeutics met its primary endpoint in a phase 2a trial of chronic kidney disease patients.The successful 42-day trial of the drug, now called ... Read more
Akebia spins off new company to develop diabetic eye disease drug

Akebia spins off new company to develop diabetic eye disease drug

January 9, 2012 2:51 pm by | 0 Comments

Akebia Therapeutics has spun off a new company, the similarly named Aerpio Therapeutics, to develop drugs for diabetic macular edema and inflammatory bowel disease.Akebia will continue developing its oral anemia ... Read more
Beyond EPO injections: Anemia treatment that comes in a pill

Beyond EPO injections: Anemia treatment that comes in a pill

August 12, 2011 12:02 pm by | 0 Comments

The pharmaceutical company Affymax just got $10 million for moving forward with an anemia treatment that would require one injection a month as opposed to as many as several shots ... Read more
Anemia treatment moves forward, Akebia raises $22 million for trials

Anemia treatment moves forward, Akebia raises $22 million for trials

April 26, 2011 9:10 am by | 0 Comments

Akebia Therapeutics has closed a $22 million series B round of investment that will take the company through a pair of phase 2b trials of its oral anemia drug.The funding ... Read more
Ohio medical companies get grants, tax credits from health reform

Ohio medical companies get grants, tax credits from health reform

November 3, 2010 2:20 pm by | 2 Comments

Sixty-two medical companies in Ohio have received grants or tax credits through a provision of this year's health reform law that's designed to fund the development of new therapies. ... Read more
Akebia gets positive results from latest oral anemia drug trial

Akebia gets positive results from latest oral anemia drug trial

October 6, 2010 9:51 am by | 0 Comments

Akebia Therapeutics Inc. has successfully completed a Phase 2a trial of its orally administered anti-anemia drug for kidney disease patients. ... Read more
Akebia begins Phase 2a trial of oral anemia drug

Akebia begins Phase 2a trial of oral anemia drug

July 22, 2010 11:31 am by | 0 Comments

Akebia Therapeutics Inc. has begun a Phase 2a clinical trial of its orally administered anemia drug.The company recently completed a Phase 1b trial of the drug, called AKB-6548, that showed ... Read more
Akebia Therapeutics aims at needs of chronic anemia patients

Akebia Therapeutics aims at needs of chronic anemia patients

June 21, 2010 5:15 pm by | 0 Comments

Being first isn’t the only goal in the drug-development business.Sometimes, an unmet patient need is so great, companies that are second or third to market stand a good chance of ... Read more
Akebia Therapeutics gets thumbs up from clinical trial, investors

Akebia Therapeutics gets thumbs up from clinical trial, investors

June 16, 2010 10:46 am by | 0 Comments

Updated 6:47 p.m.Small molecule discovery and development company Akebia Therapeutics Inc. reported positive results from a second Phase 1 clinical trial of its anemia drug, as well as the second ... Read more
Queen City Angels defy bad economy, invest in 8 health care companies

Queen City Angels defy bad economy, invest in 8 health care companies

March 3, 2010 3:02 pm by | 0 Comments

Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf).The group of accredited investors finished ... Read more
Cincinnati's Akebia starts Phase 1b clinical trial for anemia drug

Cincinnati's Akebia starts Phase 1b clinical trial for anemia drug

February 26, 2010 3:03 pm by | 1 Comments

Small molecule discovery and development company Akebia Therapeutics Inc. has started a second Phase 1 clinical trial of its anemia drug--another baton hand-off in a race with big drug companies ... Read more
Midwest health care start-ups attract $780M in 2009; down 26% from 2008

Midwest health care start-ups attract $780M in 2009; down 26% from 2008

January 29, 2010 11:35 am by | 1 Comments

Midwest health care start-ups attracted $780 million in investments in 2009, according to the BioEnterprise Midwest Health Care Venture Investment Report. While the number of companies winning investments last year ... Read more
Akebia completes Phase I trial of anemia drug, looks toward licensing deal with large pharmaceutical firm

Akebia completes Phase I trial of anemia drug, looks toward licensing deal with large pharmaceutical firm

January 5, 2010 2:47 pm by | 0 Comments

The successful completion of the trial in healthy human volunteers is a major milestone and kicks off what's shaping up to be a big year for the fledgling Cincinnati company. ... Read more